-
-
-
-
-
-
-
CervoMed adds McKinsey veteran David Quigley to board of directors
-
-
-
-
-
-
-
Chardan Capital Markets Reiterates Buy Rating on CervoMed (CRVO)
-
-
-
-
-
-
-
Morgan Stanley Downgrades CervoMed (CRVO) to Underweight
-
-
-
-
-
-
-
D. Boral Capital Starts CervoMed (CRVO) at Buy
-
-
-
-
-
-
-
Morgan Stanley Starts CervoMed (CRVO) at Overweight
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

